Double maintains 3 strategies that include MYGN - Myriad Genetics, Inc.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TIPX | 0.02% | $1.67B | 0.15% |
| JUCY | 0.11% | $269.60M | 0.6% |
| IBTP | 0.14% | $143.32M | 0.07% |
| FLDR | 0.16% | $940.32M | 0.15% |
| PSQA | -0.24% | $35.43M | 0.2% |
| IAGG | 0.26% | $10.44B | 0.07% |
| JMST | -0.30% | $4.06B | 0.18% |
| FTSM | -0.32% | $6.39B | 0.45% |
| ICSH | 0.32% | $6.03B | 0.08% |
| JSI | -0.37% | $865.26M | 0.49% |
| FMHI | 0.38% | $753.22M | 0.7% |
| IBMP | -0.40% | $553.36M | 0.18% |
| CGCB | 0.45% | $2.46B | 0.27% |
| VNLA | 0.46% | $2.62B | 0.23% |
| LMBS | -0.48% | $5.10B | 0.64% |
| WEAT | -0.49% | $117.67M | 0.28% |
| FXY | 0.75% | $820.31M | 0.4% |
| TFI | 0.83% | $3.21B | 0.23% |
| IEF | -0.95% | $34.86B | 0.15% |
| OWNS | 0.98% | $130.26M | 0.3% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -24.64% | $99.49M | 0.59% |
| VIXY | -24.53% | $165.58M | 0.85% |
| BTAL | -24.01% | $295.67M | 1.43% |
| XONE | -15.65% | $585.85M | 0.03% |
| IVOL | -14.79% | $348.25M | 1.02% |
| STOT | -13.58% | $253.88M | 0.45% |
| SCHO | -12.23% | $11.46B | 0.03% |
| FTSD | -11.67% | $231.68M | 0.25% |
| USDU | -10.79% | $163.19M | 0.5% |
| TBLL | -10.47% | $2.13B | 0.08% |
| BILS | -10.10% | $3.83B | 0.1356% |
| SPTS | -10.00% | $5.77B | 0.03% |
| XHLF | -9.36% | $1.73B | 0.03% |
| UTWO | -8.74% | $379.27M | 0.15% |
| AGZD | -8.54% | $102.60M | 0.23% |
| SHYM | -8.45% | $354.58M | 0.35% |
| IBTH | -8.36% | $1.60B | 0.07% |
| STPZ | -8.00% | $450.05M | 0.2% |
| ULST | -7.80% | $658.54M | 0.2% |
| BSMW | -7.36% | $107.29M | 0.18% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 43.23% | $44.38M | 0.5% |
| PBE | 36.06% | $223.86M | 0.58% |
| PTH | 35.75% | $100.70M | 0.6% |
| FBT | 34.58% | $1.01B | 0.54% |
| ARKG | 34.56% | $1.02B | 0.75% |
| BBH | 33.88% | $329.37M | 0.35% |
| IBB | 33.86% | $5.28B | 0.45% |
| KJUL | 33.43% | $119.28M | 0.79% |
| PINK | 33.35% | $129.96M | 0.5% |
| XBI | 33.12% | $4.84B | 0.35% |
| CGDV | 32.62% | $18.55B | 0.33% |
| GRPM | 32.19% | $454.92M | 0.35% |
| VAW | 31.99% | $2.67B | 0.09% |
| CPRJ | 31.95% | $48.21M | 0.69% |
| VIOV | 31.88% | $1.27B | 0.1% |
| FMAT | 31.86% | $426.33M | 0.084% |
| IWC | 31.80% | $817.74M | 0.6% |
| PRFZ | 31.76% | $2.36B | 0.34% |
| VTWO | 31.72% | $12.58B | 0.07% |
| NUSC | 31.70% | $1.14B | 0.31% |
Current Value
$5.551 Year Return
Current Value
$5.551 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| INNV | -0.01% | $533.30M | -21.47% | 0.00% |
| GPCR | 0.03% | $1.18B | -47.04% | 0.00% |
| CREG | 0.06% | $5.66M | -79.19% | 0.00% |
| FMS | 0.06% | $16.88B | +50.16% | 2.85% |
| ZTS | -0.11% | $70.87B | -8.94% | 1.17% |
| TTEK | 0.16% | $9.51B | -9.80% | 1.31% |
| LTM | -0.18% | $12.31B | -95.54% | 2.46% |
| EXC | 0.24% | $43.82B | +25.72% | 3.63% |
| FTS | 0.27% | $23.99B | +23.37% | 3.67% |
| VSEC | 0.28% | $2.67B | +46.83% | 0.31% |
| IMDX | -0.32% | $86.94M | +2.70% | 0.00% |
| DG | 0.33% | $25.37B | -10.94% | 2.05% |
| EHTH | -0.40% | $131.92M | -2.47% | 0.00% |
| LPRO | 0.44% | $237.18M | -64.32% | 0.00% |
| CHD | -0.45% | $24.05B | -7.40% | 1.18% |
| MQ | -0.47% | $2.72B | +3.57% | 0.00% |
| SEM | 0.50% | $1.96B | -21.69% | 2.49% |
| PSQH | 0.54% | $97.45M | -38.51% | 0.00% |
| ROK | 0.58% | $38.17B | +27.83% | 1.53% |
| NOC | 0.59% | $72.47B | +15.13% | 1.72% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| VSTS | 54.68% | $801.24M | -46.90% | 1.76% |
| MBC | 46.26% | $1.48B | -19.99% | 0.00% |
| CEVA | 43.85% | $520.18M | +16.25% | 0.00% |
| HAIN | 42.90% | $149.82M | -76.12% | 0.00% |
| DVAX | 40.74% | $1.21B | -9.21% | 0.00% |
| OC | 40.30% | $12.20B | -14.81% | 1.79% |
| IFF | 38.58% | $19.21B | -20.74% | 2.12% |
| VSH | 38.55% | $2.18B | -26.91% | 2.46% |
| DNOW | 37.31% | $1.50B | +7.61% | 0.00% |
| CC | 37.24% | $1.85B | -45.26% | 6.77% |
| MAGN | 36.85% | $454.26M | -29.39% | 0.00% |
| JAZZ | 36.61% | $6.62B | +4.14% | 0.00% |
| EPC | 36.26% | $1.15B | -38.78% | 2.44% |
| BGS | 35.25% | $354.30M | -43.87% | 16.96% |
| FBIN | 34.60% | $6.42B | -15.80% | 1.82% |
| ANDE | 34.20% | $1.29B | -22.79% | 2.54% |
| AESI | 34.13% | $1.70B | -29.35% | 6.98% |
| RMR | 34.07% | $285.90M | -25.24% | 10.58% |
| EXPI | 34.03% | $1.48B | -10.63% | 2.13% |
| GOOG | 33.67% | $2.15T | -5.20% | 0.46% |
Yahoo
Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset in full-year expectations. Management attributed the revenue decline primarily to underperformance in its GeneSight pharmacogenomic test, which was affected by UnitedHealthcare’s policy change, as well as slower-than-anticipated growth in hereditary cancer screening among unaffected individuals. CEO Sam Ra
Yahoo
MYGN sees growth in oncology and women's health testing, but GeneSight coverage loss clouds the near-term outlook.
Yahoo
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Finnhub
Presenter SpeechMatthew Sykes All right. Good afternoon, everyone. My name is Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming
Yahoo
What a brutal six months it’s been for Myriad Genetics. The stock has dropped 67.5% and now trades at $4.91, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Yahoo
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TPB | -29.76% | $1.30B | +119.21% | 0.40% |
| OSCR | -18.01% | $5.21B | +23.27% | 0.00% |
| CDRE | -17.56% | $1.29B | -6.24% | 1.14% |
| COR | -17.47% | $57.24B | +32.73% | 0.74% |
| AVDX | -16.44% | $2.03B | -19.24% | 0.00% |
| KE | -14.10% | $478.59M | -8.48% | 0.00% |
| ACI | -13.23% | $12.20B | +8.96% | 2.48% |
| MCK | -13.05% | $90.90B | +24.44% | 0.39% |
| LION | -12.11% | $1.65B | -30.69% | 0.00% |
| ANGI | -11.28% | $772.59M | -12.97% | 0.00% |
| HRTG | -11.28% | $732.99M | +271.86% | 0.00% |
| ELAN | -10.89% | $7.17B | +3.00% | 0.00% |
| LIVN | -10.34% | $2.49B | -13.50% | 0.00% |
| FYBR | -9.75% | $9.12B | +39.78% | 0.00% |
| HALO | -9.67% | $6.52B | +3.16% | 0.00% |
| WST | -9.29% | $15.98B | -31.05% | 0.37% |
| NRDS | -7.79% | $830.82M | -25.07% | 0.00% |
| SYPR | -7.16% | $46.42M | +9.19% | 0.00% |
| VSTA | -6.90% | $341.66M | +42.00% | 0.00% |
| MO | -6.86% | $97.93B | +26.25% | 6.95% |
